|
Decoupling Mechanical and Inflammatory Stimuli in Discogenic Low Back Pain |
1R01AR080926-01 |
|
NIAMS |
2022 |
|
To explore the molecular and cellular effects of transient DUX4 expression in skeletal muscle |
1R01AR081228-01 |
|
NIAMS |
2022 |
|
Obesity promoting protein malonylation and chondrocyte metabolic dysfunction in osteoarthritis development |
1R15AR080813-01 |
|
NIAMS |
2022 |
|
Investigating how Mylpf-regulated sarcomere formation influences limb skeletal development |
1R15AR081019-01 |
|
NIAMS |
2022 |
|
Systemic delivery of muscle stem cell for muscle disease therapy |
1R21AR079033-01A1 |
|
NIAMS |
2022 |
|
Disease Modeling of Skeletaland Cardiac Muscle in DMD/BMD using Patient-Specific iPS Cells |
1R21AR079236-01A1 |
|
NIAMS |
2022 |
|
Ex vivo expansion of skeletal muscle satellite cells |
1R21AR079855-01A1 |
|
NIAMS |
2022 |
|
PKR as a therapeutic target for muscular dystrophy |
1R21AR080362-01A1 |
|
NIAMS |
2022 |
|
CD10-bound Exosomes from IFP-MSC Degrade Substance P Controlling OA Inflammation and Pain |
1R21AR080388-01A1 |
|
NIAMS |
2022 |
|
Bioerodible corticosteroid microparticle-drug as an intra-articular drug delivery system for osteoarthritis therapy |
1R21AR080502-01A1 |
|
NIAMS |
2022 |